Microdosing GLP-1s brings some safety risks
The following sources give you the unfiltered picture - clinical evidence, regulatory context, and safety data straight from the organizations that publish it: FDA.gov - official FDA communications on compounded semaglutide, tirzepatide, and the 503B Bulks List proposal (April 30, 2026)
Estradiol supplementation in postmenopausal women doubles rebound-like release of growth hormone (GH) triggered by sequential infusion and withdrawal of somatostatin: evidence that estrogen facilitates endogenous GH-releasing hormone drive
Fuel Your Bodys Defense with One of Natures Most Powerful Antioxidant Allies
Andrew Huberman , and Joe Rogan have emerged as leading voices on the science of longevity
Environmental and lifestyle model (Decourt et al., 2022)